Juventas Therapeutics, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Cleveland OH United States (2007)

Organization Overview

First Clinical Trial
2010
NCT01082094
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Juventas Cell Therapy Ltd.